Stock listing
SION Stock Price, News, Filings & Events — Sionna Therapeutics, Inc.
Selected listing: SION · NASDAQ · USD · US
This page tracks Sionna Therapeutics, Inc.'s SION:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SION:NASDAQ. SION:NASDAQ is the stock-level entry point for investors researching Sionna Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sionna Therapeutics, Inc. is a public company traded under the ticker SION in the American market. The company has a market capitalization of approximately $2.06 billion. Sionna Therapeutics focuses on developing innovative therapies in the healthcare sector.

- Ticker
- SION:NASDAQ
- Asset type
- Stock
- Market cap
- $354.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Sionna Therapeutics, Inc. SION:NASDAQ stock context
This page tracks Sionna Therapeutics, Inc.'s SION:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SION:NASDAQ. SION:NASDAQ is the stock-level entry point for investors researching Sionna Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sionna Therapeutics, Inc. is a public company traded under the ticker SION in the American market. The company has a market capitalization of approximately $2.06 billion. Sionna Therapeutics focuses on developing innovative therapies in the healthcare sector.
Latest news from Sionna Therapeutics, Inc.
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
August 10, 2026
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
August 6, 2026
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
May 27, 2026
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
Sionna Therapeutics Reports First Quarter 2026 Financial Results
May 12, 2026
Research Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for SION:NASDAQ.
Sionna Therapeutics, Inc. company profile
View the public company page for Sionna Therapeutics, Inc. on 6ix.
Sionna Therapeutics, Inc. news
Read company news and market updates connected to Sionna Therapeutics, Inc..
Sionna Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Sionna Therapeutics, Inc..